Quidel Stock Today
| QDEL Stock | USD 36.12 0.52 1.46% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Quidel is selling for 36.12 as of the 15th of March 2025. This is a 1.46% increase since the beginning of the trading day. The stock's lowest day price was 35.82. Quidel has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 15th of December 2024 and ending today, the 15th of March 2025. Click here to learn more.
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company was founded in 1979 and is headquartered in San Diego, California. Quidelortho Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 67.45 M outstanding shares of which 4.35 M shares are at this time shorted by private and institutional investors with about 4.94 trading days to cover. More on Quidel
Moving against Quidel Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Quidel Stock Highlights
| CEO and President and Director | Douglas Bryant |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Quidel (QDEL) is traded on NASDAQ Exchange in USA. It is located in 9975 Summers Ridge Road, San Diego, CA, United States, 92121 and employs 6,600 people. Quidel is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.4 B. Quidel conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 67.45 M outstanding shares of which 4.35 M shares are at this time shorted by private and institutional investors with about 4.94 trading days to cover.
Quidel currently holds about 264 M in cash with 83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.0.
Check Quidel Probability Of Bankruptcy
Ownership AllocationThe majority of Quidel outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Quidel to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Quidel. Please pay attention to any change in the institutional holdings of Quidel as this could imply that something significant has changed or is about to change at the company.
Check Quidel Ownership Details
Quidel Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Quidel market risk premium is the additional return an investor will receive from holding Quidel long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | 0.0202 | |||
| Treynor Ratio | 14.63 |
Quidel Stock Against Markets
Quidel Corporate Management
| Ruben Argueta | Director Relations | Profile | |
| Juliet Cunningham | Vice Relations | Profile | |
| Michelle JD | Chief Officer | Profile | |
| Chockalingam Palaniappan | Chief Officer | Profile | |
| Joseph CPA | Chief Officer | Profile | |
| Louise Brandy | Senior Officer | Profile | |
| Tamara Ranalli | Molecular Leader | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quidel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Quidel Stock please use our How to buy in Quidel Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quidel. If investors know Quidel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quidel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quidel is measured differently than its book value, which is the value of Quidel that is recorded on the company's balance sheet. Investors also form their own opinion of Quidel's value that differs from its market value or its book value, called intrinsic value, which is Quidel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quidel's market value can be influenced by many factors that don't directly affect Quidel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quidel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quidel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quidel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.